Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

L-Glutamic acid

Copy Product Info
😃Good
Catalog No. T2A2497Cas No. 56-86-0
Alias glutamic acid, glutacid, (S)-Glutamic acid, (+)-L-Glutamic acid

L-Glutamic acid is an excitatory amino acid neurotransmitter and a Glutamic acid receptor agonist, including metabolic glutamic acid receptor (mGluR), AMPA receptor, NMDA receptor and KA receptor. L-Glutamic acid has an excitatory effect on the process of DA release from dopaminergic nerve endings. L-Glutamic acid can be used in the research of neurological diseases. L-Glutamic acid acts on ionic and metabolic Glutamic acid receptors.

L-Glutamic acid

L-Glutamic acid

Copy Product Info
😃Good
Purity: 99.55%
Catalog No. T2A2497Alias glutamic acid, glutacid, (S)-Glutamic acid, (+)-L-Glutamic acidCas No. 56-86-0
L-Glutamic acid is an excitatory amino acid neurotransmitter and a Glutamic acid receptor agonist, including metabolic glutamic acid receptor (mGluR), AMPA receptor, NMDA receptor and KA receptor. L-Glutamic acid has an excitatory effect on the process of DA release from dopaminergic nerve endings. L-Glutamic acid can be used in the research of neurological diseases. L-Glutamic acid acts on ionic and metabolic Glutamic acid receptors.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 g$42-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.55%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

L-Glutamic acid AI Summary
L-Glutamic acid exhibits a diverse array of bioactivities across various glutamate receptors and related systems. It acts as an agonist at metabotropic glutamate receptors (mGluRs), showing potencies indicated by EC50 values of 610.0 nM for mGluR2 and 1050.0 nM for mGluR1. It also exhibits antagonist activity against NMDA receptors with an IC50 value of 70.0 nM and at AMPA receptors with an IC50 value of 340.0 nM. In assays, L-Glutamic acid demonstrates potent inhibition of glutamate transporters, particularly EAAT1, EAAT2, and EAAT3, with IC50 values ranging from 11,000 nM to 50,118 nM. It shows binding affinities toward AMPA receptors (IC50 = 1300.0 nM), kainate receptors (IC50 = 700.0 nM), and NMDA receptors (IC50 = 200.0 nM), suggesting a broad spectrum impact on the glutamatergic system. Additionally, the compound has demonstrated bioactivity influencing ionotropic glutamate receptors, with different nanomolar range affinities for AMPA, kainate, and NMDA receptor subtypes, and showing agonistic activities in calcium influx assays in various receptor mutants expressed in HEK293 cells. The calculated pKa values (2.23, 4.21, and 9.54) and a partition coefficient (logP) of 3.88 suggest that L-Glutamic acid is moderately lipophilic and capable of crossing cell membranes. Overall, L-Glutamic acid's broad-ranging modulatory effects on multiple glutamate receptor subtypes and its varied affinity and potency in different assays and receptors illustrate its potential as a multi-target compound in neurological and pharmacological research..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
L-Glutamic acid is an excitatory amino acid neurotransmitter and a Glutamic acid receptor agonist, including metabolic glutamic acid receptor (mGluR), AMPA receptor, NMDA receptor and KA receptor. L-Glutamic acid has an excitatory effect on the process of DA release from dopaminergic nerve endings. L-Glutamic acid can be used in the research of neurological diseases. L-Glutamic acid acts on ionic and metabolic Glutamic acid receptors.
Targets&IC50
CHO cells:1.2 μM, HEK293 cells:0.06 μM, BHK-21 cells:1.8 μM (EC50), Oocyte:0.45 μM
In vitro
METHODS: SH-SY5Y cells were treated with L-Glutamic acid (10, 20, 30 mM) for 3 hours, and cell viability was detected using the MTT assay.
RESULTS: L-Glutamic acid reduced the viability of SH-SY5Y cells. [1]
Synonymsglutamic acid, glutacid, (S)-Glutamic acid, (+)-L-Glutamic acid
Chemical Properties
Molecular Weight147.13
FormulaC5H9NO4
Cas No.56-86-0
Smiles[C@H](CCC(O)=O)(C(O)=O)N
Relative Density.1.54 g/cm3. Temperature:20 °C.
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 8.27 mg/mL (56.21 mM), Sonication is recommended.
DMSO: < 1 mg/mL (insoluble or slightly soluble)
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM6.7967 mL33.9836 mL67.9671 mL339.8355 mL
5 mM1.3593 mL6.7967 mL13.5934 mL67.9671 mL
10 mM0.6797 mL3.3984 mL6.7967 mL33.9836 mL
20 mM0.3398 mL1.6992 mL3.3984 mL16.9918 mL
50 mM0.1359 mL0.6797 mL1.3593 mL6.7967 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy L-Glutamic acid | purchase L-Glutamic acid | L-Glutamic acid cost | order L-Glutamic acid | L-Glutamic acid chemical structure | L-Glutamic acid in vitro | L-Glutamic acid formula | L-Glutamic acid molecular weight